Aeolus Pharmaceuticals, Inc.  

(Public, OTCMKTS:AOLS)   Watch this stock  
Find more results for OTC:AOLS
+0.004 (1.69%)
Apr 22 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.24 - 0.26
52 week 0.22 - 0.47
Open 0.24
Vol / Avg. 0.00/24,530.00
Mkt cap 32.29M
P/E     -
Div/yield     -
EPS -0.08
Shares 134.55M
Beta 0.56
Inst. own 80%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -87.64% -81.67%
Operating margin -87.64% -68.69%
EBITD margin - -68.53%
Return on average assets -118.02% -199.13%
Return on average equity -573.00% -
Employees 4 -
CDP Score - -


Suite 150, 26361 Crown Valley Parkway
United States - Map
+1-949-4819825 (Phone)
+1-919-5588686 (Fax)

Website links


Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. Its lead compound, AEOL 10150, is entering human clinical trials in oncology where it is used in combination with radiation therapy. AEOL 10150 had been tested in two Phase-I clinical trials. The compound is also being developed as a medical countermeasure (MCM) against the pulmonary sub-syndrome of acute radiation syndrome (pulmonary acute radiation syndrome or Lung-ARS), as well as the gastrointestinal sub-syndrome of acute radiation syndrome (GI-ARS). It is also being developed for use as a countermeasure for exposure to chemical vesicants, such as chlorine gas and sulfur mustard gas. These compounds, known as metalloporphyrins, scavenge reactive oxygen species (ROS) at the cellular level, mimicking the effect of the body�s own natural antioxidant enzyme superoxide dismutase (SOD). Its lead compound, AEOL 10150, is a metalloporphyrin designed to neutralize reactive oxygen and nitrogen species.

Officers and directors

David C. Cavalier Chairman of the Board, Interim Chief Financial Officer
Age: 43
John L. McManus President, Chief Executive Officer
Age: 48
John M. Clerici Director
Mitchell D. Kaye J.D. Director
Age: 45
Jeffrey A. Scott M.D. Director
Age: 55
John M. Farah Jr., Ph.D. Independent Director
Amit Kumar PhD Independent Director
Age: 49